Logo image of NFYS

ENPHYS ACQUISITION CORP (NFYS) Stock Fundamental Analysis

NYSE:NFYS - New York Stock Exchange, Inc. - KYG3167L1095 - Common Stock - Currency: USD

11  +0.01 (+0.09%)

Fundamental Rating

1

NFYS gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. NFYS has a bad profitability rating. Also its financial health evaluation is rather negative. NFYS does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year NFYS was profitable.
In the past year NFYS had a positive cash flow from operations.
NFYS Yearly Net Income VS EBIT VS OCF VS FCFNFYS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 5M 10M

1.2 Ratios

Industry RankSector Rank
ROA 18.05%
ROE 23.26%
ROIC N/A
ROA(3y)6.05%
ROA(5y)N/A
ROE(3y)6.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NFYS Yearly ROA, ROE, ROICNFYS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 5 10 15

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for NFYS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NFYS Yearly Profit, Operating, Gross MarginsNFYS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023

More info and screens

3

2. Health

2.1 Basic Checks

The number of shares outstanding for NFYS has been reduced compared to 1 year ago.
Compared to 1 year ago, NFYS has a worse debt to assets ratio.
NFYS Yearly Shares OutstandingNFYS Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 10M 20M 30M 40M
NFYS Yearly Total Debt VS Total AssetsNFYS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 100M 200M 300M

2.2 Solvency

NFYS has an Altman-Z score of 4.88. This indicates that NFYS is financially healthy and has little risk of bankruptcy at the moment.
The Debt to FCF ratio of NFYS is 0.15, which is an excellent value as it means it would take NFYS, only 0.15 years of fcf income to pay off all of its debts.
NFYS has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
Even though the debt/equity ratio score it not favorable for NFYS, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.15
Altman-Z 4.88
ROIC/WACCN/A
WACCN/A
NFYS Yearly LT Debt VS Equity VS FCFNFYS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 0.16 indicates that NFYS may have some problems paying its short term obligations.
NFYS has a Quick Ratio of 0.16. This is a bad value and indicates that NFYS is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.16
Quick Ratio 0.16
NFYS Yearly Current Assets VS Current LiabilitesNFYS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 200K 400K 600K 800K 1M

More info and screens

1

3. Growth

3.1 Past

NFYS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.51%, which is quite impressive.
EPS 1Y (TTM)24.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-44.05%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 32.35, the valuation of NFYS can be described as expensive.
NFYS is valuated rather expensively when we compare the Price/Earnings ratio to 24.21, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 32.35
Fwd PE N/A
NFYS Price Earnings VS Forward Price EarningsNFYS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 19.03
EV/EBITDA N/A
NFYS Per share dataNFYS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NFYS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ENPHYS ACQUISITION CORP

NYSE:NFYS (7/24/2024, 8:14:53 PM)

11

+0.01 (+0.09%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners4.93%
Inst Owner Change-46.39%
Ins Owners41.11%
Ins Owner Change0%
Market Cap133.65M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 32.35
Fwd PE N/A
P/S N/A
P/FCF 19.03
P/OCF 19.03
P/B 2.53
P/tB 2.53
EV/EBITDA N/A
EPS(TTM)0.34
EY3.09%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.58
FCFY5.25%
OCF(TTM)0.58
OCFY5.25%
SpS0
BVpS4.35
TBVpS4.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 18.05%
ROE 23.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)6.05%
ROA(5y)N/A
ROE(3y)6.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.15
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 57.16%
Current Ratio 0.16
Quick Ratio 0.16
Altman-Z 4.88
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-44.05%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y1.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1463.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1463.12%
OCF growth 3YN/A
OCF growth 5YN/A